Whole-genome sequencing is set to revolutionize pregnancy by enabling embryo screening to reduce genetic risks, potentially transforming IVF practices, but raising ethical and accessibility concerns.
The article explores Silicon Valley's push towards genetically customizing babies through advanced embryo screening and polygenic risk scoring, raising ethical questions about eugenics, accessibility, and the accuracy of current genetic prediction methods, amid a broader cultural movement advocating for increased reproductive technology use to counteract declining birth rates.
The Alabama Supreme Court's ruling that frozen embryos are legally children has sparked new scrutiny of in vitro fertilization (IVF) and the ethical questions surrounding it, particularly in the absence of regulations on screening embryos for sex and other traits. The lack of regulation has led to controversial practices such as selecting embryos based on sex, eye color, and even non-disease traits. The ruling has reignited debates over the personhood of embryos and the ethical implications of genetic testing in reproductive technology, as the industry continues to evolve and expand with hefty investments.